Publications
5674 Results
- Journal / Conference
- Journal of Urology Vol. 197, No. 4S, Supplement, PNFLBA-10; AUA Annual Meeting (May 12-16, 2017, Boston, MA), oral presentation
- Year
- 2017
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0337
A phase III blinded study of immediate post-TURBT instillation of gemcitabine versus saline in patients with newly diagnosed or occasionally recurring grade I/II non-muscle invasive cancer: SWOG S0337 (http://www.jurology.com/article/S0022-5347(17)39232-7/fulltext)
- Journal / Conference
- Journal of Clinical Oncology 35, 2017 (suppl 4S; abstract 585); ASCO GI Cancers Symposium (January 19-21, 2017, San Francisco, CA), poster
- Year
- 2017
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- C89803
Long-chain omega-3 fatty acid and fish intake after colon cancer diagnosis and disease-free, recurrence-free, and overall survival in CALGB 89803 (Alliance)
- Journal / Conference
- American Society of Preventive Oncology Annual Meeting (March 11-14, 2017, Seattle, Washington), poster
- Year
- 2017
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/N0147
Pre-diagnostic physical activity and outcomes in patients with stage III colon cancer: A correlative analysis of phase III trial NCCTG N0147 (Alliance)
- Journal / Conference
- Proceedings of the American AACR Association for Cancer Research April 2017 Vol 58, abst. 1776 p. 456; AACR Annual Meeting (April 1-5, 2017, Washington, DC), poster
- Year
- 2017
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-9313
Impact of homologous recombination deficiency (HRD) biomarkers on outcomes in triple negative breast cancer (TNBC) patients treated with AC chemotherapy (SWOG S9313)
- Journal / Conference
- Cancer Jul 15;123(14):2688-2697; 2017 Mar 23 [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Melanoma
- PMID
- PMID28334439
- PMC
- PMC5498223
- Study Number(s)
- CTSU/E2607
A phase II trial of dasatinib in patients with unresectable locally advanced or stage IV mucosal, acral and vulvovaginal melanoma: a trial of the ECOG-ACRIN Cancer Research Group (E2607)
- Journal / Conference
- Journal of the American Medical Association Jun 20;317(23):2392-2401
- Year
- 2017
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID28632865
- PMC
- PMC5545896
- Study Number(s)
- CTSU/C80405
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial
- Journal / Conference
- Nutrients Apr 12;9(4):378. doi: 10.3390/nu9040378
- Year
- 2017
- Research Committee(s)
- Cancer Control
- PMID
- PMID28417914
- PMC
- PMC5409717
- Study Number(s)
- SWOG-9217
Interactions of the insulin-like growth factor axis and vitamin D in prostate cancer risk in the Prostate Cancer Prevention Trial
- Journal / Conference
- FASEB Journal April 31:167.8; Experimental Biology/American Society of Nutrition annual meeting (April 22-26, 2017, Chicago, IL), poster
- Year
- 2017
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000C
Dietary patterns and lung function: assessment of the Alternative Health Eating Index-2010 (AHEI-2010) and rate of change in forced expiratory volume in the first second (FEV1)
- Journal / Conference
- American Hepato-Panreato-Biliary Association Annual Meeting (March 29-April 2, 2017, Miami Beach, Florida), oral
- Year
- 2017
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S1505
SWOG S1505: A randomized phase II study of perioperative mFOLFIRINOX vs. gemcitabine/nab-paclitaxel as therapy for resectable pancreatic adenocarcinoma
- Journal / Conference
- Lancet Oncology Dec;18(12):1610-1623, 2017; Nov 9 [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Lung
- PMID
- PMID29129443
- PMC
- PMC5789803
- Study Number(s)
- CTSU/E1505